Overview

VeraFlo With Prontosan® and Wound and Fracture Healing.

Status:
Terminated

Trial end date:
2017-12-01

Target enrollment:
0

Participant gender:
All

Summary

To answer the question: "Do Prontosan instillations decrease time to wound and fracture healing and decrease bacterial load compared to wound vac treatment without Prontosan?," we will enroll up to 30 subjects (for an anticipated 20 complete data sets) into this trial. The subjects will be split equally into two different groups by randomization. One groups will have wound vac therapy with Prontosan, and one group will have wound vac therapy without Prontosan. Data related to wound and fracture healing and bacterial load will be assessed between the two groups to determine if wound vac therapy with Prontosan speeds up healing time and decreases bacterial load.

Phase:

N/A

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Brett Crist

Criteria

Inclusion Criteria:

- Patients 18 years and older

- Patients who will be undergoing surgical management (including the use of NPWT
therapy) of an infected lower extremity status-post open reduction and internal
fixation (ORIF)

Exclusion Criteria:

- Pregnant females

- Incarcerated patients and those not able to give informed consent